EventsAntibiotics 2026—Advances in Antimicrobial Action and Resistance
Published
This submission belongs to the session S4. Conventional and Novel Approaches in the Discovery of New Antimicrobial Agents of the event Antibiotics 2026—Advances in Antimicrobial Action and Resistance
Published date
04 May, 2026
Academic Editor
author-avatarJordi Vila
Citation
Francesca Berini, Oleksandr Yushchuk, Lei Zhong, Christian Rückert-Reed, Letizia Bartolone, Davide Malacarne, Tobias Busche, Jörn Kalinowski, Roderich D. Süssmuth, Flavia Marinelli, Genome mining as a tool for identifying novel glycopeptide antibiotics: insights from kineomicins, in Proceedings of Antibiotics 2026—Advances in Antimicrobial Action and Resistance, Barcelona, 11 May–14 May 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Genome mining as a tool for identifying novel glycopeptide antibiotics: insights from kineomicins

image
image
Lei Zhong 3
Letizia Bartolone 1
Davide Malacarne 1
image
1. Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
2. Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, Lviv, Ukraine
3. Institute of Chemistry, Technische Universität Berlin, Berlin, Germany
4. Technology Platform Genomics, CeBiTec, Bielefeld University, Bielefeld, Germany
5. Medical School OWL, Bielefeld University, Bielefeld, Germany
Abstract
Keywords
Glycopeptide antibiotics
genome mining
biosynthetic gene cluster
fermentation